Back to search results
NCT07311889

Patient Satisfaction and Recovery Outcomes Associated With Perioperative ELIXIR MD Use

Enrolling by Invitation
Not specifiedAges 18+Observational
Elixir MD Inc
~300 participants
Updated 2026-02-17 on ClinicalTrials.gov
What's tested:Perioperative photobiomodulation light therapy

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient-reported satisfaction with postoperative recovery
Measured over From baseline (preoperative) through 10 days postoperatively

Conditions

Postoperative Pain
Postoperative Edema
Postoperative Ecchymosis
Surgical Wound Healing
Postsurgical Recovery

Explore related trials

Ecchymosis following surgical procedureNon-healing surgical woundPlastic Surgery ProcedurePostoperative deathPost-Operative PainPostsurgical Recovery

Where it's being run

1 sites across 1 states
California1

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adults aged 18 years or older undergoing elective plastic surgery (facial or body procedures) at a participating plastic surgery practice where the ELIXIR MD™ device is used as part of standard perioperative care.
Able to provide informed consent and complete brief patient-reported questionnaires.

Exclusion

Pregnancy.
Basal cell carcinoma, thyroid disorders, or malignant tumors.
History of photosensitive skin disease or photosensitivity.
Epilepsy or seizure disorders.
Recent use of photosensitizing medications, including isotretinoin within the past 6 months; tetracyclines or ciprofloxacin within the past 5 days; chlorpromazine within the past 8 days; methotrexate within the past 3 days; or amiodarone, per physician discretion.

What this trial measures

  • Patient-reported satisfaction with postoperative recoveryFrom baseline (preoperative) through 10 days postoperatively

    Patient-reported satisfaction with postoperative recovery assessed using a study-specific Global Satisfaction item adapted from Global Rating of Change (GROC) methodology. Responses are collected on a numeric Likert scale during routine postoperative follow-up and analyzed descriptively. Mean satisfaction score (0-10) % of patients reporting high satisfaction (≥7)